rs879255251
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000373631.8(CRB2):βc.3089_3104delβ(p.Arg1030LeufsTer106) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000386 in 1,374,404 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.000053 ( 0 hom., cov: 34)
Exomes π: 0.000037 ( 0 hom. )
Consequence
CRB2
ENST00000373631.8 frameshift
ENST00000373631.8 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.86
Genes affected
CRB2 (HGNC:18688): (crumbs cell polarity complex component 2) This gene encodes a member of a family of proteins that are components of the Crumbs cell polarity complex. In mammals, members of this family are thought to play a role in many cellular processes in early embryonic development. A similar protein in Drosophila determines apicobasal polarity in embryonic epithelial cells. Mutations in this gene are associated with focal segmental glomerulosclerosis 9, and with ventriculomegaly with cystic kidney disease. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-123373608-TGGCGCGGCCCCGGCCC-T is Pathogenic according to our data. Variant chr9-123373608-TGGCGCGGCCCCGGCCC-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1324169.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-123373608-TGGCGCGGCCCCGGCCC-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRB2 | NM_173689.7 | c.3089_3104del | p.Arg1030LeufsTer106 | frameshift_variant | 10/13 | ENST00000373631.8 | NP_775960.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRB2 | ENST00000373631.8 | c.3089_3104del | p.Arg1030LeufsTer106 | frameshift_variant | 10/13 | 1 | NM_173689.7 | ENSP00000362734 | P1 | |
CRB2 | ENST00000359999.7 | c.3089_3104del | p.Arg1030LeufsTer138 | frameshift_variant | 10/10 | 2 | ENSP00000353092 | |||
CRB2 | ENST00000460253.1 | c.2093_2108del | p.Arg698LeufsTer106 | frameshift_variant, NMD_transcript_variant | 5/9 | 2 | ENSP00000435279 |
Frequencies
GnomAD3 genomes AF: 0.0000528 AC: 8AN: 151596Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
8
AN:
151596
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000368 AC: 45AN: 1222808Hom.: 0 AF XY: 0.0000434 AC XY: 26AN XY: 598848
GnomAD4 exome
AF:
AC:
45
AN:
1222808
Hom.:
AF XY:
AC XY:
26
AN XY:
598848
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000528 AC: 8AN: 151596Hom.: 0 Cov.: 34 AF XY: 0.0000405 AC XY: 3AN XY: 74058
GnomAD4 genome
AF:
AC:
8
AN:
151596
Hom.:
Cov.:
34
AF XY:
AC XY:
3
AN XY:
74058
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
CRB2-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 14, 2022 | The CRB2 c.3089_3104del16 variant is predicted to result in a frameshift and premature protein termination (p.Arg1030Leufs*106). This variant has been reported in the compound heterozygous state in a fetus with ventriculomegaly, hydrocephalus, and echogenic kidneys (Zhang et al. 2020. PubMed ID: 32051522). This variant is reported in 1 of 59,000 alleles in gnomAD: However, the quality of this call is questionable and should be interpreted with caution (http://gnomad.broadinstitute.org/variant/9-126135887-TGGCGCGGCCCCGGCCC-T). Frameshift variants in CRB2 are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 04, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at